Clindamycin, later-generation cephalosporins, and fluoroquinolones carry the highest risk of triggering a C. diff infection. But nearly any antibiotic can cause one. A large case-control study of over 36 million outpatient prescriptions found that clindamycin raised the odds of community-associated C. diff by roughly 25 times compared to not taking antibiotics, making it the single riskiest option. The overall risk remains low in absolute terms (fewer than 10 cases per 10,000 prescriptions even for the worst offenders), but some drugs are dramatically more dangerous than others.
The Highest-Risk Antibiotics
Three classes consistently top the list: lincosamides (clindamycin), cephalosporins, and fluoroquinolones. Within each class, individual drugs vary quite a bit.
Clindamycin stands alone at the top. It had an adjusted odds ratio of 25.4 for C. diff and the highest absolute infection rate of any outpatient antibiotic: about 9.7 cases per 10,000 prescriptions. It is commonly prescribed for skin infections and dental procedures, so the risk is worth knowing about.
Cephalosporins, especially later-generation versions, are the next tier. Cefixime (odds ratio 12.0), cefdinir (11.0), cefuroxime (9.6), and cefpodoxime (9.2) all carry substantial risk. These are frequently prescribed for sinus infections, ear infections, and urinary tract infections. Earlier-generation options like cephalexin have a much lower odds ratio of about 2.9, putting them closer to the moderate-risk category.
Fluoroquinolones like ciprofloxacin (odds ratio 6.8) and moxifloxacin (4.7) round out the high-risk group. Ciprofloxacin had an absolute infection rate of 6.6 per 10,000 prescriptions. Levofloxacin was lower at 2.5.
Moderate-Risk Antibiotics
Amoxicillin/clavulanate (commonly sold as Augmentin) is one of the most prescribed antibiotics in the world, and it carries a surprisingly high odds ratio of 8.5 for C. diff. That places it in the same range as some cephalosporins. Plain amoxicillin, by contrast, has a much lower odds ratio of about 2.0. The addition of clavulanate broadens the drug’s spectrum of activity, which means it kills more types of gut bacteria and creates a bigger opening for C. diff.
Other penicillins fall in the moderate range. Dicloxacillin has an odds ratio of 5.9, while ampicillin sits at 2.6 and plain penicillin at 1.8.
Sulfamethoxazole/trimethoprim (Bactrim), commonly used for urinary tract infections, has an odds ratio of about 2.2. Nitrofurantoin, another common UTI drug, comes in at 1.8.
Lower-Risk Antibiotics
Macrolides like azithromycin (the well-known Z-pack) have relatively modest risk, with an odds ratio of 1.3 and an absolute infection rate of just 0.85 per 10,000 prescriptions. Clarithromycin is slightly higher at 1.8, and erythromycin sits at 1.5.
Tetracyclines are the safest class studied. Doxycycline showed an odds ratio of 0.96, meaning it carried essentially no increased risk of C. diff at all. Minocycline actually appeared protective, with an odds ratio of 0.79. Their absolute infection rate was among the lowest measured: about 1.15 per 10,000 prescriptions for doxycycline. When a clinician has a choice between antibiotic classes, tetracyclines are often the gentlest option for the gut.
Why Certain Antibiotics Are Worse
Your gut contains trillions of bacteria that normally keep C. diff in check. One key way they do this is by producing certain bile acids that suppress C. diff growth. When a broad-spectrum antibiotic wipes out large swaths of that bacterial community, C. diff loses its main competition and can multiply rapidly.
But the damage goes beyond just killing good bacteria. Research from the American Society for Microbiology found that the antibiotics most associated with C. diff also directly weaken your gut’s physical defenses, independent of the microbiome. These drugs reduce the mucus layer that lines the intestinal wall, creating easier access for C. diff and its toxins to reach the tissue underneath. They also impair immune cells’ ability to engulf and kill bacteria, and they make the gut lining more permeable to C. diff toxins. So the highest-risk antibiotics hit you with a double blow: they clear the path for C. diff to grow and simultaneously make your body less able to fight it off.
When Symptoms Typically Appear
Most C. diff infections develop while you’re still taking antibiotics or shortly after finishing a course. The classic symptoms are watery diarrhea (three or more loose stools a day), fever, abdominal cramping, and loss of appetite. The risk window extends well beyond the last pill, though. You remain vulnerable for several weeks after stopping antibiotics because your gut flora takes time to recover. Some people develop symptoms a month or more after their prescription ends, which can make the connection easy to miss.
How C. Diff Is Treated
If you develop C. diff, the first step is usually stopping the antibiotic that triggered it, when possible. For an initial episode, current guidelines from the Infectious Diseases Society of America favor fidaxomicin over vancomycin. Both drugs work equally well at clearing the initial infection, but fidaxomicin is a narrower-spectrum agent that does less collateral damage to your remaining gut bacteria. That translates to fewer recurrences. Vancomycin remains a solid alternative, particularly where cost or availability is a factor.
Recurrence is the most frustrating aspect of C. diff. For people who have a repeat episode within six months, guidelines suggest adding bezlotoxumab, a treatment given by infusion that neutralizes the toxin C. diff produces. It does not kill the bacteria itself but helps prevent the cycle of repeated infections. People over 65, those with weakened immune systems, and those with severe initial episodes tend to benefit the most.
Reducing Your Risk During Antibiotic Treatment
The most effective way to lower C. diff risk is to avoid unnecessary antibiotics altogether. If you do need one, the specific drug matters. When your infection can be treated with a tetracycline like doxycycline instead of a fluoroquinolone or clindamycin, the C. diff risk drops by an order of magnitude. This is worth a conversation with your prescriber, especially if you’ve had C. diff before or have other risk factors like being over 65.
Probiotics have been studied as a preventive measure during antibiotic courses, with several types showing reduced C. diff rates in facility-level studies. However, results are inconsistent, and the benefit appears to depend heavily on the specific probiotic strain used. Not all products on store shelves contain strains with meaningful evidence behind them, and many studies have been criticized for not specifying which strains were tested. Probiotics are not a reliable substitute for choosing a lower-risk antibiotic in the first place.